| Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC) KE Caudle, HM Dunnenberger, RR Freimuth, JF Peterson, JD Burlison, ... Genetics in Medicine 19 (2), 215-223, 2017 | 402 | 2017 |
| Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process K E Caudle, T E Klein, J M Hoffman, D J Muller, M Whirl-Carrillo, L Gong, ... Current drug metabolism 15 (2), 209-217, 2014 | 382 | 2014 |
| A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily RL Blanchard, RR Freimuth, J Buck, RM Weinshilboum, MWH Coughtrie Pharmacogenetics and Genomics 14 (3), 199-211, 2004 | 373 | 2004 |
| Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time—using genomic data to individualize treatment protocol SJ Bielinski, JE Olson, J Pathak, RM Weinshilboum, L Wang, KJ Lyke, ... Mayo Clinic Proceedings 89 (1), 25-33, 2014 | 284 | 2014 |
| Development and use of active clinical decision support for preemptive pharmacogenomics GC Bell, KR Crews, MR Wilkinson, CE Haidar, JK Hicks, DK Baker, ... Journal of the American Medical Informatics Association 21 (e1), e93-e99, 2014 | 210 | 2014 |
| Clinical pharmacogenetics implementation consortium guidelines for HLA‐B genotype and abacavir dosing MA Martin, TE Klein, BJ Dong, M Pirmohamed, DW Haas, DL Kroetz Clinical Pharmacology & Therapeutics 91 (4), 734-738, 2012 | 204 | 2012 |
| The pharmacogenomics research network translational pharmacogenetics program: overcoming challenges of real‐world implementation AR Shuldiner, MV Relling, JF Peterson, K Hicks, RR Freimuth, W Sadee, ... Clinical Pharmacology & Therapeutics 94 (2), 207-210, 2013 | 174 | 2013 |
| Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting LV Kalman, JAG Agúndez, ML Appell, JL Black, GC Bell, S Boukouvala, ... Clinical Pharmacology & Therapeutics 99 (2), 172-185, 2016 | 164 | 2016 |
| Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA‐B Genotype and Abacavir Dosing: 2014 Update MA Martin, JM Hoffman, RR Freimuth, TE Klein, BJ Dong, M Pirmohamed, ... Clinical Pharmacology & Therapeutics 95 (5), 499-500, 2014 | 136 | 2014 |
| Pharmacogenomic assessment of carboxylesterases 1 and 2 S Marsh, M Xiao, J Yu, R Ahluwalia, M Minton, RR Freimuth, PY Kwok, ... Genomics 84 (4), 661-668, 2004 | 131 | 2004 |
| SNP interaction detection with random forests in high-dimensional genetic data SJ Winham, CL Colby, RR Freimuth, X Wang, M de Andrade, M Huebner, ... BMC bioinformatics 13, 1-13, 2012 | 116 | 2012 |
| The pharmacogenomics research network translational pharmacogenetics program: outcomes and metrics of pharmacogenetic implementations across diverse healthcare systems JA Luzum, RE Pakyz, AR Elsey, CE Haidar, JF Peterson, M Whirl‐Carrillo, ... Clinical Pharmacology & Therapeutics 102 (3), 502-510, 2017 | 112 | 2017 |
| Human cytosolic sulfotransferase database mining: identification of seven novel genes and pseudogenes RR Freimuth, M Wiepert, CG Chute, ED Wieben, RM Weinshilboum The pharmacogenomics journal 4 (1), 54-65, 2004 | 104 | 2004 |
| Developing knowledge resources to support precision medicine: principles from the Clinical Pharmacogenetics Implementation Consortium (CPIC) JM Hoffman, HM Dunnenberger, J Kevin Hicks, KE Caudle, ... Journal of the American Medical Informatics Association 23 (4), 796-801, 2016 | 100 | 2016 |
| Human sulfotransferase SULT2A1 pharmacogenetics: genotype-to-phenotype studies BA Thomae, BW Eckloff, RR Freimuth, ED Wieben, RM Weinshilboum The pharmacogenomics journal 2 (1), 48-56, 2002 | 100 | 2002 |
| A weighted random forests approach to improve predictive performance SJ Winham, RR Freimuth, JM Biernacka Statistical Analysis and Data Mining: The ASA Data Science Journal 6 (6 …, 2013 | 99 | 2013 |
| A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer AH Wagner, B Walsh, G Mayfield, D Tamborero, D Sonkin, K Krysiak, ... Nature genetics 52 (4), 448-457, 2020 | 88 | 2020 |
| Harmonizing clinical sequencing and interpretation for the eMERGE III network H Zouk, E Venner, NJ Lennon, DM Muzny, D Abrams, S Adunyah, ... The American Journal of Human Genetics 105 (3), 588-605, 2019 | 85 | 2019 |
| CSER and eMERGE: current and potential state of the display of genetic information in the electronic health record BH Shirts, JS Salama, SJ Aronson, WK Chung, SW Gray, LA Hindorff, ... Journal of the American Medical Informatics Association 22 (6), 1231-1242, 2015 | 84 | 2015 |
| An informatics research agenda to support precision medicine: seven key areas JD Tenenbaum, P Avillach, M Benham-Hutchins, MK Breitenstein, ... Journal of the American Medical Informatics Association 23 (4), 791-795, 2016 | 81 | 2016 |
Marc S. WilliamsProfessor and Director Emeritus, Genomic Medicine Institute, GeisingerBestätigte E-Mail-Adresse bei geisinger.edu
